Biogen Inc. stock price
BIIB · NMS · stock
$227.07▼ 1.62 (-0.71%)
Open
$227.02
Prev close
$228.69
Day high
$229.41
Day low
$224.45
52-wk high
$230.49
52-wk low
$136.94
P/E (TTM)
20.10×
Net margin
16.50%
Biogen Inc. (BIIB) is a US-listed company (NYSE / Nasdaq). Traddx shows its live price, interactive candlestick charts, quarterly financials straight from SEC filings, a Groww-style health scorecard, and support/resistance — plus Athena, our US research analyst, for a plain-English take.
Quarterly financials
| Quarter | Revenue $M | YoY | Net profit $M | EPS $ |
|---|---|---|---|---|
| Q1 2026 | 2,477.80 | +1.90% | 319.50 | 2.15 |
| Q3 2025 | 2,534.70 | +2.80% | 466.50 | 3.17 |
| Q2 2025 | 2,645.50 | +7.30% | 634.80 | 4.33 |
| Q1 2025 | 2,431.00 | +6.10% | 240.50 | 1.64 |
| Q3 2024 | 2,465.80 | -2.50% | 388.50 | 2.66 |
| Q2 2024 | 2,464.90 | +0.40% | 583.60 | 4.00 |
| Q1 2024 | 2,290.50 | -7.00% | 393.40 | 2.70 |
| Q3 2023 | 2,530.30 | +0.90% | -68.10 | -0.47 |
Figures in US$ millions, latest first (source: SEC filings).